Kanger 205 now. Volume 140m

All vaccines counter on the rise....all gloves down.

Our patience and beliefs are payoff...

Mad...we are on same page

rocky_88, Careplus is an understatement. I am thinking of Supermax LOL

Western Vaccines all got huge pre-orders by rich countries. It will take long time to reach Malaysia.

Solutions, Kanger, Bintai, HWGB..+ Pharma, Dpharma

I don't want to be injected with "some new technology" vaccine. Still prefer the old and trusted inactivated vaccine with dead virus.

https://www.nbcnews.com/health/health-news/pfizer-s-covid-19-vaccine-promising-many-questions-remain-n1247102

"We don't know anything about groups they didn't study, like children, pregnant women, highly immunocompromised people and the eldest of the elderly," Dr. Gregory Poland, director of the Mayo Clinic's Vaccine Research Group in Rochester, Minnesota, said. And would people previously sick with Covid-19 be protected against reinfection? That remains unclear.

What's more, the Pfizer vaccine uses a brand new technology called messenger-RNA, or mRNA. It has never been approved for human vaccination before. Instead of using bits of virus to provoke an immune response, the mRNA trains the immune system to target the spike protein found on the surface of the coronavirus.

These couple of days..I observed many other counters talking about vaccines, which is a good thing as it raise awareness. Matter of time buyers will come in full force.

Only 80 MPs allowed in Parliament...how to have majority to reject?

What is most interesting is if Pharmaniaga wants to buy Sinopharm assuming it get clearance to use, it will have to apply for MOH registration which most probably will be approved. And if Kanger also apply for it, will it get approved? Of course it will as technically everything is the same. Or shall Kanger be named as exclusive distributor in all approvals as it has the deal already with Sinopharm? This remained to be seen. But one thing for sure...it will be approved one way or another.

Kanger by appointing Zuellig Pharma to be their distributor means direct supply to private hospitals and clinics. Whether Pharma or Dpharma gets it through Kanger for KKM depends very much on Chinese Government as these are usually G to G deals.

Unless some favorable news came out of Sinopharm like public approvals to use internationally.

Just follow the big boys...I only tumpang

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3103415

Operator will maintain price until after PP

Price controlled counter

pertamina, don't frighten

This is becoming an "old boys club" hahahaha

Kstar prices shoot up every day but actual buy sell queue is very small.
As of now there are 29 sellers for prices between 0.84 - 0.86 Total queue volume: 943,000
56 buyers for prices 0.815 - 0.835 Total queue volume: 2,447,000)

They are interested only to push up the prices only, for whatever reason they themselves know.
Looked very likely ownself sell, ownself buy.

Good stock market sentiments today after Biden win...rising tide will lift all boats.

Parking brake released, light on, safety belts on, gear engaged, fuel full, tires ok, engine warmed up....ready to Vrroommm...good luck every one

Far water cannot save near fire. So make the best of what you have today.

I thinkTitijaya sign sometime April 2020, a deal involving only PPE, medical equipment, test kits and medical real estate with a subsidiary of Sinopharm. They are not involved with vaccine.

Earlier, the WHO said it was monitoring the mutation, which was a "concern," but that it was too early to tell if it posed any risk to humans or would undo the impact of a potential vaccine.

"This is a global pandemic and many millions of people have been infected, many millions of animals have been exposed," Dr. Mike Ryan, executive director of the WHO Health Emergencies Program, said during a virtual press conference from Geneva.

"Right now, the evidence that we have doesn't suggest that this variant is in any way different in the way it behaves ... it is still the same virus."

https://www.nbcnews.com/news/world/who-downplays-coronavirus-mink-mutation-risk-after-denmark-orders-huge-n1246726

Tomorrow I queue again :)

Yes, Kanger has got strong cables in China.

@Jtan63, tq for info.

Not many people know Kanger export river sand to Hong Kong and China from Malaysia.
Also I don't know Kanger have a JV on anti bacterial coating which is used in hospitals, airports globally.

https://www.theedgemarkets.com/article/kanger-distribute-antimicrobial-coating-solutions-locally-and-overseas

https://www.theedgemarkets.com/article/kanger-facilitate-sand-exports-mainland-china-hong-kong

@henry, we share the info only for general knowledge. Correct me if I am wrong.

brutus...if approval is obtained, I plan to hold until 6 mths later whatever the price will be

I think among all vaccine counters, Kanger is most proactive in planning and implementing strategies to roll out the vaccine to Malaysian public.

in contrast, what are the stages of planning , stages of testing of vaccines for HWGB, Bintai, Solution, Pharma or Dpharma?

Vaccine testing is very important especially at 3rd stage where mass testing is carried out. Chinese vaccines are tested in Indonesia, UAE, Brazil other than China itself. Other vaccine manufacturers Astrazenneca, Pfizer, Moderna, etc also doing the same. The results must be presented to their health authorities / WHO for scrutiny before it can be used internationally.
The results are expected be available by end of Dec or early Jan for scrutiny and eventually approval. That's the main reason why vaccine can only be available 1st quarter 2021 onwards.

Yes. NPRA is the regulator body.

May the world be more united.

All drugs must be registered through NPRA / MOH. But it is NOT necessary must be by Pharma or Dpharma. Any other companies also can register.
You guys can go to npra.gov.my to check it out. Click on Industry / product search, select pharmaceutical /manufacturer, type name of manufacturer.
Last time I typed Sinopharm, 9 products were registered. These are not vaccine but other products manufactured by Sinopharm.

As far as Bintai or HWGB, do some research to see what are their vaccines and what stage of development testing they are in.

To set up sub contract local filling and get facility accredited by manufacturer would take many years. No time for that. Ready to use vials is the way to go.

Of course, home country must approve it first as WHO members are the nations, in this case China and not private enterprises, although CBNG is a state owned enterprise.

By the way, if you guys go to npra.gov.my search engine, you can find 9 Sinopharm products already approved by MOH.

If I read correctly somewhere, Sinopharm together with Sinovac are pre approved by WHO as China joined Covac to supply vaccine.

Monday...Sinopharm vaccine distributor Kanger will fly.

There are reports that full results of 3rd stage trials would be available this or next month, thereafter presented to the authorities. So yes, it might be possible to push out before CNY in Feb 2021.

Interesting read

https://www.abc.net.au/news/2020-11-07/chinese-coronavirus-trial-vaccine-phase-3-covid-19/12851880

https://www.theedgemarkets.com/article/kanger-distribute-antimicrobial-coating-solutions-locally-and-overseas

No infections among 56,000 people who traveled abroad after receiving Sinopharm-developed COVID-19 vaccine: developer
Source: Global Times Published: 2020/11/7 13:32:29


None of the 56,000 people who were inoculated with a COVID-19 vaccine and travelled abroad have contracted the coronavirus, Sinopharm's chairman said on Friday.

Sinopharm Chairman Liu Jingzhen, said at a conference on Friday that some 100,000 people have been vaccinated with the company's vaccine and have shown none adverse reactions so far. Among those who were inoculated and travelled aboard, none have been infected with the virus, said Liu.

Some of those other received the emergency-use vaccine are employees of China National Petroleum Corporation, China Petrochemical Corporation and Technology giant Huawei.

Liu said that there are 99 people in Huawei's Mexico office, and 81 were vaccinated. Ten unvaccinated employees contracted with the virus in an outbreak in this office.

The fact that no one who received the vaccine has been infected, serves as more anecdotal evidence that the vaccine is working, Tao Lina, a Shanghai-based vaccine expert told the Global Times.

The data signals Sinopharm vaccine maybe close to being released on the market, Tao predicted.

Liu said that since June, Sinopharm's phase three clinic trial in dozens of countries and regions, including the UAE, Egypt, Bahrain, Peru and Morocco have more than 50,000 participants.

The results have moved the UAE ,Bahrain and other countries to approve urgent use of the Sinopharm vaccine, according to Liu, who told the conferred that he is "still alive and kicking, with no adverse reaction," after he was vaccinated in March.

Liu said the examples and scientific data prove the effectiveness of the company's COVID-19 vaccine.

Liu said Sinopharm is to produce about 100 million doses of vaccine by the end of the year, and estimates it will make 1 billion doses next year, to guarantee supplies especially for use by Chinese people, said Liu.

China has approved three vaccines for urgent use. Their vaccines have been given to high-risk groups, such as medical staff, diplomats sent to most-affected countries, and employees sent overseas under the Belt and Road Initiative.

These people have stayed abroad several months after being vaccinated, Zhou Song, general counsel CNBG, a Sinopharm subsidy said in September, according to the WeChat account of the State-owned Assets Supervision and Administration Commission of the State Council.

I think you are right on side movements and more so, PP is being done. Big price fluctuations would not be allowed for the time being. Maybe end next week, perhaps?

Mad..it is MOU. But for Chinese, any MOU or handshake deal is as good as a promise.

@rockrziq, From KJ's twitter there's Halal issue. Indonesia reported that Chinese vaccine has halal certificate. In fact the Ruler of Dubai took Sinopharm lends some credibility on it.

From reports, adenovirus Cansino is a single shot virus but how long it can last is not known. Sinopharm uses 2 shots are recommended 28 day apart. it is like a booster shot. The big difference is Sinopharm is a inactivated vaccine which means the virus are dead in its process. whereas adenovirus are engineered modified flu virus.

That's why much studies need to be made but in the absence of it, it is best to go with the one which is most widely tested. Still MOH / WHO will make the final call.

But it is prudent multi sourcing is the way to go forward.

One thing about penny stock. There will be many daytime contra players. They will sell at every 1 sen gain. And the floating shares in the market is very huge. That's why it won't go up much, at least for now. It can only go up incrementally. But when prices go higher, these players will fade away slowly looking for those cheaper stock to play with.